Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07150299
Recruiting
Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
Not applicable · Austria · 1 site
Registry update: 2 Sept 2025
NCT06726161
Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Phase 1/2 · United States · 13 sites
Registry update: 28 Sept 2026
NCT07000279
Recruiting
Assessment of Feasibility, Functionality and Usability of an Hybrid Assistive Exoskeleton for Upper Limb
Not applicable · Italy · 1 site
Registry update: 29 Sept 2025
NCT06414590
Recruiting
Neoadjuvant Tebentafusp for Uveal Melanoma
Phase 2 · United States · 2 sites
Registry update: 12 Jun 2026
NCT07054931
Recruiting
Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV
Phase 2 · United Kingdom · 3 sites
Registry update: 7 Jul 2026
NCT07099430
Recruiting
A Trial of LBL-024 Monotherapy or Combination With Toripalimab in Patients With Advanced Melanoma.
Phase 1/2 · China · 16 sites
Registry update: 21 Oct 2026
NCT07102901
Recruiting
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Phase 2 · China · 2 sites
Registry update: 10 Sept 2025
NCT07163403
Recruiting
First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers
Phase 1 · Spain · 1 site
Registry update: 13 Apr 2026
NCT07086131
Recruiting
A Study Investigating the Impact of IMT With CR On Exercise Responses In HF
Not applicable · United States · 1 site
Registry update: 7 Aug 2026
NCT06133426
Recruiting
Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients
Not applicable · France · 1 site
Registry update: 15 Sept 2025
NCT06835725
Recruiting
Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer
Phase 2 · Canada · 2 sites
Registry update: 24 Jun 2026
NCT06941857
Recruiting
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Phase 2 · United States · 1 site
Registry update: 5 May 2026
2025-521152-34-00
Recruiting
A study to evaluate acalabrutinib, in combination with the R-CHOP standard of care, for previously untreated mantle cell lymphoma in Spain.
Phase 2 · Spain · 21 sites
Registry update: 3 Nov 2026
NCT07123727
Recruiting
A Study to Examine Anktiva for the Treatment of COVID-19.
Phase 2 · United States · 1 site
Registry update: 24 Sept 2026
NCT07151690
Recruiting
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
Phase 2 · China · 1 site
Registry update: 23 Jul 2026
2024-519713-65-00
Recruiting
Single Arm Study of WSD0922-FU for NSCLC Patients with C797S mutation
Phase 2 · France · 5 sites
Registry update: 29 Jun 2026
NCT07194005
Recruiting
Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
Phase 2 · China · 1 site
Registry update: 26 Sept 2025
NCT06784726
Recruiting
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
Phase 2 · United States · 1 site
Registry update: 28 Aug 2026
NCT07082179
Recruiting
A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer
Phase 2 · China · 1 site
Registry update: 11 Feb 2026
NCT07207577
Recruiting
Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD
Not applicable · France · 1 site
Registry update: 7 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.